'It doesn't clump, so it's safe. It spreads, so it works.' — Dr. Jimyung Seo on the clinical value of GOURI
The biostimulator market is evolving rapidly, with formulation innovation setting new standards in clinical practice. Dexlevo's GOURI — the world's first fully liquid PCL biostimulator — was designed to address the structural limitations of particulate formulations, including the risk of nodules and vascular compromise. Since its international launch in 2021, no cases of unresolved nodules or granulomas have reportedly been documented in cannula-based procedures. Dr. Jimyung Seo of Galleria Dermatology, Gaepo-Dogok Branch, who has accumulated 80 to 100 cases over five months since adopting GOURI, says she has seen clinically meaningful tightening and volumizing outcomes even after a single session. From dilution protocols to EBD combination strategies and adverse event management, we explore the realities of GOURI in clinical practice.
#MedicalAestheticNews #Dexlevo #GOURI #GalleriaDermatologyGaepoDogok #DrJimyungSeo
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=11351

Comments
Post a Comment